| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Author Index
|
|
|
|
4 |
8S1 |
p. S389-S412
|
article
|
| 2 |
Calendar
|
|
|
|
4 |
8S1 |
p. S413-S414
|
article
|
| 3 |
Editorial Board
|
|
|
|
4 |
8S1 |
p. i-ii
|
article
|
| 4 |
Revised Draft Guidelines for Proteomic Data Publication
|
|
|
|
4 |
8S1 |
p. ix-xi
|
article
|
| 5 |
Session 2: Bioinformatics
|
|
|
|
4 |
8S1 |
p. S17-S34
|
article
|
| 6 |
Session 3: Functional Proteomics-Cell Signaling
|
|
|
|
4 |
8S1 |
p. S35-S43
|
article
|
| 7 |
Session 4: Functional Proteomics-Protein-Protein Interactions and Networks
|
|
|
|
4 |
8S1 |
p. S44-S59
|
article
|
| 8 |
Session 5: HUPO Initiatives-Antibodies
|
|
|
|
4 |
8S1 |
p. S60-S67
|
article
|
| 9 |
Session 6: HUPO Initiatives-Brain
|
|
|
|
4 |
8S1 |
p. S68-S73
|
article
|
| 10 |
Session 7: HUPO Initiatives-Glycoproteomics
|
|
|
|
4 |
8S1 |
p. S74-S76
|
article
|
| 11 |
Session 8: HUPO Initiatives-Liver
|
|
|
|
4 |
8S1 |
p. S77-S80
|
article
|
| 12 |
Session 9: HUPO Initiatives-New Technologies
|
|
|
|
4 |
8S1 |
p. S81-S84
|
article
|
| 13 |
Session 10: HUPO Initiatives-Plasma
|
|
|
|
4 |
8S1 |
p. S85-S87
|
article
|
| 14 |
Session 11: HUPO Initiatives-Standards
|
|
|
|
4 |
8S1 |
p. S88
|
article
|
| 15 |
Session 41: Industry Sponsored Symposia
|
|
|
|
4 |
8S1 |
p. S387-S388
|
article
|
| 16 |
Session 1: Invited Speaker Abstracts
|
|
|
|
4 |
8S1 |
p. S1-S16
|
article
|
| 17 |
Session 13: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Cancer Proteomics
|
|
|
|
4 |
8S1 |
p. S98-S139
|
article
|
| 18 |
Session 14: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Clinical Biomarker Discovery
|
|
|
|
4 |
8S1 |
p. S140-S169
|
article
|
| 19 |
Session 15: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Heart & Stroke
|
|
|
|
4 |
8S1 |
p. S170-S176
|
article
|
| 20 |
Session 16: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Liver
|
|
|
|
4 |
8S1 |
p. S177-S182
|
article
|
| 21 |
Session 17: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Neuroproteomics
|
|
|
|
4 |
8S1 |
p. S183-S196
|
article
|
| 22 |
Session 18: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Obesity & Diabetes
|
|
|
|
4 |
8S1 |
p. S197-S200
|
article
|
| 23 |
Session 23: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Other
|
|
|
|
4 |
8S1 |
p. S226-S232
|
article
|
| 24 |
Session 19: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Other Tissues
|
|
|
|
4 |
8S1 |
p. S201-S209
|
article
|
| 25 |
Session 20: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Plasma
|
|
|
|
4 |
8S1 |
p. S210-S215
|
article
|
| 26 |
Session 21: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Target Identification and Validation
|
|
|
|
4 |
8S1 |
p. S216-S219
|
article
|
| 27 |
Session 22: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Toxicology
|
|
|
|
4 |
8S1 |
p. S220-S225
|
article
|
| 28 |
Session 24: Model Organisms-Microbial Proteomes
|
|
|
|
4 |
8S1 |
p. S233-S251
|
article
|
| 29 |
Session 25: Model Organisms-Other Non-Mammalian Proteomes
|
|
|
|
4 |
8S1 |
p. S252-S255
|
article
|
| 30 |
Session 26: Model Organisms-Plant Proteomes
|
|
|
|
4 |
8S1 |
p. S256-S261
|
article
|
| 31 |
Session 39: News Corner
|
|
|
|
4 |
8S1 |
p. S360-S382
|
article
|
| 32 |
Session 12: Organellar Proteomics
|
|
|
|
4 |
8S1 |
p. S89-S97
|
article
|
| 33 |
Session 40: Other
|
|
|
|
4 |
8S1 |
p. S383-S386
|
article
|
| 34 |
Session 27: Post-Translational Modifications-Glycosylation and Glycoproteomics
|
|
|
|
4 |
8S1 |
p. S262-S267
|
article
|
| 35 |
Session 28: Post-Translational Modifications-Other Post-Translational Modifications
|
|
|
|
4 |
8S1 |
p. S268-S272
|
article
|
| 36 |
Session 29: Post-Translational Modifications-Phosphorylation and Phosphoproteomics
|
|
|
|
4 |
8S1 |
p. S273-S284
|
article
|
| 37 |
Session 30: Proteomics in Biotechnology
|
|
|
|
4 |
8S1 |
p. S285-S289
|
article
|
| 38 |
Session 31: Proteomics Technologies-2D Electrophoresis
|
|
|
|
4 |
8S1 |
p. S290-S298
|
article
|
| 39 |
Session 33: Proteomics Technologies-Mass Spectrometry-based Quantitative Proteomics
|
|
|
|
4 |
8S1 |
p. S314-S329
|
article
|
| 40 |
Session 32: Proteomics Technologies-Mass Spectrometry Technology
|
|
|
|
4 |
8S1 |
p. S299-S313
|
article
|
| 41 |
Session 34: Proteomics Technologies-Nanotechnology/Protein Arrays
|
|
|
|
4 |
8S1 |
p. S330-S338
|
article
|
| 42 |
Session 37: Proteomics Technologies-Other
|
|
|
|
4 |
8S1 |
p. S351-S357
|
article
|
| 43 |
Session 36: Proteomics Technologies-Protein Chemistry
|
|
|
|
4 |
8S1 |
p. S348-S350
|
article
|
| 44 |
Session 35: Proteomics Technologies-Protein Prefractionation Technologies
|
|
|
|
4 |
8S1 |
p. S339-S347
|
article
|
| 45 |
Session 38: Structural Proteomics
|
|
|
|
4 |
8S1 |
p. S358-S359
|
article
|
Journal description